Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Lemoine

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|September 28, 2011
Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesisMaud Lemoine, Lawrence Serfaty
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen: toward elimination of nucleic acid testing?Maud Lemoine, Karine Lacombe
Seminars in Liver Disease|May 1, 2014
Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areasMaud Lemoine, Mark Thursz
Nature Reviews. Gastroenterology & Hepatology|February 25, 2015
Viral hepatitis: Scaling up HCV treatment in resource-limited countriesMaud Lemoine, Mark Thursz
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Is aspartate aminotransferase-to-platelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?Asgeir Johannessen, Maud Lemoine
Presse Medicale (Paris, France : 1983)|July 5, 2011
[Nonalcoholic fatty liver disease]Maud Lemoine, Lawrence Serfaty
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Early age at diagnosis of hepatocellular carcinoma in sub-Saharan AfricaYusuke Shimakawa, Maud Lemoine
Journal De La Societe De Biologie|December 25, 2007
[Polysaccharides enzymatic degradation in heterogeneous phase: example of agarases and carrageenases]Maud Lemoine, William Helbert
Clinics and Research in Hepatology and Gastroenterology|October 20, 2012
Liver injury in HIV monoinfected patients: should we turn a blind eye to it?Maud Lemoine, Patrick Ingiliz
Journal of Hepatology|August 30, 2020
Reply to: "Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age"Yusuke Shimakawa, Maud Lemoine
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|September 28, 2011
Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesisMaud Lemoine, Lawrence Serfaty
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen: toward elimination of nucleic acid testing?Maud Lemoine, Karine Lacombe
Seminars in Liver Disease|May 1, 2014
Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areasMaud Lemoine, Mark Thursz
Nature Reviews. Gastroenterology & Hepatology|February 25, 2015
Viral hepatitis: Scaling up HCV treatment in resource-limited countriesMaud Lemoine, Mark Thursz
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Is aspartate aminotransferase-to-platelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?Asgeir Johannessen, Maud Lemoine
Presse Medicale (Paris, France : 1983)|July 5, 2011
[Nonalcoholic fatty liver disease]Maud Lemoine, Lawrence Serfaty
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Early age at diagnosis of hepatocellular carcinoma in sub-Saharan AfricaYusuke Shimakawa, Maud Lemoine
Journal De La Societe De Biologie|December 25, 2007
[Polysaccharides enzymatic degradation in heterogeneous phase: example of agarases and carrageenases]Maud Lemoine, William Helbert
Clinics and Research in Hepatology and Gastroenterology|October 20, 2012
Liver injury in HIV monoinfected patients: should we turn a blind eye to it?Maud Lemoine, Patrick Ingiliz
Journal of Hepatology|August 30, 2020
Reply to: "Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age"Yusuke Shimakawa, Maud Lemoine
Pageof 16